Accueil A new Institute dedicated to combating leukemia

A new Institute dedicated to combating leukemia

A new Leukemia Institute in Paris

Who are we?

Who are we?

The Leukemia Institute is a University Hospital Institute founded in 2023 by the Assistance Publique–Hôpitaux de Paris, INSERM, the Collège de France, and Paris Cité University, and is funded by the Paris Cité University Foundation (FUPC). It represents an unprecedented collaboration that brings together clinical and scientific expertise to reach a shared goal: transforming the care of patients with acute leukemia and related diseases.

The Institute’s integrated structure houses the research teams and clinical departments to foster synergies and help turn scientific discoveries into medical advances for patients.

The Institute aims to become a world-leading leukemia center, building on its scientific and medical excellence, strategic partnerships, and innovative training programs.

The Leukemia Institute: key figures

1st

leukemia treatment and research center in France

16

research teams

10

clinical departments

4

clinical laboratories

Our 4 areas of expertise

Research

16 teams covering basic, translational, and clinical research as well as care pathway improvement

Patient care

10 clinical departments for children, teenagers, adults, and seniors

Training programs

Training programs

Unique training opportunities for students, researchers, healthcare professionals, and industry partners

Innovation

Innovative patents and industrial partnerships, including our drug screening platform

Our goals

The Leukemia Institute has four strategic goals:

1 Identify predisposing factors for leukemia and develop preventive treatments

2 Understand the diversity of leukemias and design novel treatments

3 Explore what causes treatment resistance

4 Improve patients’ quality of life

Stéphanie CHAMBAUD

Clinical departments

Department of Adult Hematology, Olivier Hermine

Necker Hospital

149 rue de Sèvres 75015 Paris

Department of senior hematology, Lionel Adès

Saint-Louis Hospital

1 avenue Claude Vellefaux 75010 Paris

Outpatient Hemato-oncogenetics Unit, Marie Sébert

Saint-Louis Hospital

1 avenue Claude Vellefaux 75010 Paris

Adolescent and Young Adult Unit, Nicolas Boissel

Saint-Louis Hospital

1 avenue Claude Vellefaux 75010 Paris

Department of clinical hematology and cell therapy, Thorsten Braun

Avicenne Université Sorbonne Paris Nord Hospital

125 Route de Stalingrad 93000 Bobigny

Department of Pharmacology and Clinical Investigations, Vincent Lévy

Saint-Louis Hospital

1 avenue Claude Vellefaux 75010 Paris

Hematology Transplant Unit , Régis Peffault de Latour

Saint-Louis Hospital

1 avenue Claude Vellefaux, 75010 Paris

Department of adult hematology, Emmanuel Raffoux

Saint-Louis Hospital

1 avenue Claude Vellefaux 75010 Paris

Department of clinical haematology, Olivier Hermine

Cochin–Port Royal Hospital

27 rue du Faubourg Saint Jacques – 75014 Paris

Department of Paediatric Hematology and Immunology, Jean-Hugues Dalle

Robert-Debré Hospital

48 boulevard Sérurier 75019 Paris

History of hematology on the Saint-Louis Hospital campus

1945

Professor Jean Bernard and his team at Saint-Louis Hospital achieve the first ever leukemia remission

1980

Professor Jean Dausset is awarded the Nobel Prize for the discovery of tissue groups enabling bone marrow transplants

1980

George Flandrin and Marie-Thérèse Daniel create an international morphological classification for acute leukemia

1989

Professor Eliane Gluckman performs the world’s first umbilical cord blood transplant

1990

Professor Hugues de Thé identifies the PML gene

1990

Professors Laurent Degos and Pierre Fenaux treat acute promyelocytic leukemia with retinoic acid

1990

Professor Hervé Dombret creates national cooperative groups for the treatment of acute myeloid and lymphoid leukemia

1998

Professors Hélène Cavé and Bernard Grandchamp demonstrate the predictive value of minimal residual disease

2000

Advances in molecular hematology at Saint-Louis, Necker, and Robert-Debré Hospitals, helping to better understand the molecular diversity of leukemias

2016

Professor André Baruchel treats French child with CAR-T cells for refractory leukemia for the first time at Robert-Debré Hospital

2016

New insights into the diversity of congenital bone marrow failure

2019

First national multidisciplinary molecular boards created for acute leukemia

2020

Innovative treatments for bone marrow failure with PNH

2023

Creation of the Leukemia Institute, recognized as a University Hospital Institute under France’s 2030 national investment plan

Find out more

Host foundation and founding members

Frequently Asked Questions

What is a University Hospital Institute?

University Hospital Institutes (IHU) aim to promote translational research, i.e. research that is rapidly transformed into solutions for patient.

They bring together clinical, scientific, and technological expertise in a specific field to fast-track advances in care and innovation.
Since 2010, 19 IHUs have been created in France.

The Leukemia Institute was designated as an IHU under France’s 2030 national investment plan and received €30 million in funding.

When was the Leukemia Institute created?

The Institute was created in 2023 as part of France’s 2030 national investment program.
It was selected as being an ambitious scientific project with recognized expertise in hematology.

Who are the founding members?

The Leukemia Institute was founded by the Assistance Publique–Hôpitaux de Paris (AP-HP), INSERM, the Collège de France, and Paris Cité University.
The IHU is funded by the Université Paris Cité Foundation (FUPC).